FIELD: experimental medicine.
SUBSTANCE: method involves introducing 0.07-0.08 ml of complete Freund adjuvant and subjecting animal organism to immobilization stress action for 1 h every day during a period from 14-th to 28-th day.
EFFECT: high reproducibility of the disease for investigating predisease-to-disease transition conditions.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF EXPERIMENTAL PSEUDORHEUMATISM MODELLING | 2007 |
|
RU2351021C1 |
| METHOD FOR CREATION BIOLOGICAL MODEL OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN EXPERIMENT | 2016 |
|
RU2612843C1 |
| METHOD FOR MODELING ARTHRITIS | 0 |
|
SU1748174A1 |
| AGENT FOR TREATING INFLAMMATORY DISEASES OF THE JOINTS | 2019 |
|
RU2707278C1 |
| BIOLOGICALLY ACTIVE AGENT EXHIBITING A LOCAL ANTI-INFLAMMATORY EFFECT IN ADJUVANT ARTHRITIS | 2021 |
|
RU2771567C1 |
| WATER-SOLUBLE TYROSINE DERIVATIVES HAVING ANALGESIC, ANTI-INFLAMMATORY AND ANTIEDEMIC ACTION | 2017 |
|
RU2678563C1 |
| TYROSINE HETEROCYCLIC AMIDES, HAVING ANALGESIC, ANTI-INFLAMMATORY AND ANTIEDEMIC ACTION | 2018 |
|
RU2685505C1 |
| PROCESS FOR SIMULATING RHEUMATOID ARTHRITIS | 0 |
|
SU1098027A1 |
| METHOD OF SIMULATING RHEUMATOID ARTHRITIS | 0 |
|
SU764661A1 |
| COMBINATIONS OF PALMITOYLETHANOLAMIDE FOR TREATING CHRONIC PAIN | 2018 |
|
RU2701720C1 |
Authors
Dates
2007-08-27—Published
2005-11-21—Filed